Skip to content

Effect of Increased Fruit and Vegetable Intake on Chronic Obstructive Pulmonary Disease (COPD)

Effect of Increased Fruit and Vegetable Intake on Airway Inflammation and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00435708
Acronym
DISCO
Enrollment
81
Registered
2007-02-15
Start date
2007-02-28
Completion date
2009-09-30
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, Fruit, Vegetables, Oxidative stress, Inflammation

Brief summary

Chronic obstructive pulmonary disease (COPD) is the UK's fastest growing fatal disease and is estimated to cost the health service close to £1 billion every year. Around 80,000 people in Northern Ireland suffer from COPD. COPD is clinically defined as a slowly progressive condition characterised by airflow limitation, which is largely irreversible. Chronic inflammation and oxidative stress are key components of the underlying pathological process resulting in airflow limitation. Dietary factors and nutrients that have antioxidant or anti-inflammatory properties are therefore of interest with respect to the aetiology of COPD. The antioxidant vitamins C, E and beta-carotene are all present in the lung milieu. Such antioxidants represent the lung's first line of defence against oxygen free radicals. Observational studies indicate that a low dietary intake of antioxidant nutrients, or foods rich in antioxidants (e.g. fruit and vegetables), is associated with decreased lung function and increased risk of COPD. To date, there have been no food-based dietary interventions investigating the effect of increased fruit and vegetable intake on COPD. The investigators propose to recruit people with mild to moderate COPD and low fruit and vegetable intakes (\<=2 portions daily) and randomise them to one of two study arms for 12 weeks - either to increase fruit and vegetable consumption to at least 5 portions a day, or to follow their normal diet. Airway and systemic oxidative stress and inflammation will be assessed at baseline and post-intervention in order to determine if fruit and vegetables have the potential to alleviate the oxidative stress and airway inflammation associated with COPD.

Interventions

BEHAVIORAL5 portions fruit and vegetables/day

Participants consume \> = 5 portions fruit and veg per day

Sponsors

Queen's University, Belfast
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* moderate to severe COPD (according to GOLD classification) * oxygen saturation \>= 92 KPa * symptomatically stable * habitually low fruit and vegetable intakes (\<=2 portions daily) * exercise limited by shortness of breath (rather than e.g. angina, arthritis)

Exclusion criteria

* diabetes * taking antioxidant supplements or drugs * oxygen saturation \<8KPa

Design outcomes

Primary

MeasureTime frameDescription
Self-reported Intake of Fruit and Vegetables (Number of Portions Per Day);12 weeksA series of 7-day diet histories were completed by each participant at weeks 0 and 12 in order to assess baseline diet and self-reported compliance with the intervention; average daily FV intake was then hand-counted from these records;
Markers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane12 WeeksMarkers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane ng/ml

Secondary

MeasureTime frameDescription
Biochemical Markers of Nutritional Status Plasma Vitamin C12 weeksPlasma vitamin C concentration umol/L

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Low FV Group
Control - two or less portions fruit and vegetables/day
41
High FV Group
5 portions fruit and vegetables/day 5 portions fruit and vegetables/day: Participants consume \> = 5 portions fruit and veg per day
40
Total81

Baseline characteristics

CharacteristicLow FV GroupHigh FV GroupTotal
Age, Continuous61.2 years
STANDARD_DEVIATION 8.3
63.2 years
STANDARD_DEVIATION 9.1
62.2 years
STANDARD_DEVIATION 8.71
Region of Enrollment
United Kingdom
41 participants40 participants81 participants
Sex: Female, Male
Female
16 Participants19 Participants35 Participants
Sex: Female, Male
Male
25 Participants21 Participants46 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 410 / 40
other
Total, other adverse events
0 / 410 / 40
serious
Total, serious adverse events
0 / 410 / 40

Outcome results

Primary

Markers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane

Markers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane ng/ml

Time frame: 12 Weeks

ArmMeasureValue (GEOMETRIC_MEAN)
ControlMarkers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane1.70 ng/ml
InterventionMarkers of Airway Inflammation in Induced Sputum - Sputum 8-isoprostane1.83 ng/ml
Primary

Self-reported Intake of Fruit and Vegetables (Number of Portions Per Day);

A series of 7-day diet histories were completed by each participant at weeks 0 and 12 in order to assess baseline diet and self-reported compliance with the intervention; average daily FV intake was then hand-counted from these records;

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
ControlSelf-reported Intake of Fruit and Vegetables (Number of Portions Per Day);1.9 Portions per dayStandard Deviation 0.5
InterventionSelf-reported Intake of Fruit and Vegetables (Number of Portions Per Day);6.1 Portions per dayStandard Deviation 1.8
Secondary

Biochemical Markers of Nutritional Status Plasma Vitamin C

Plasma vitamin C concentration umol/L

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
ControlBiochemical Markers of Nutritional Status Plasma Vitamin C33.44 umol/lStandard Deviation 21.19
InterventionBiochemical Markers of Nutritional Status Plasma Vitamin C47.64 umol/lStandard Deviation 19.23

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026